Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Mizuho Raises Amgen Target Price to $352.00

Guavy AI Editorial Team
Instruments
AMGN
Share

Amgen Inc (NASDAQ:AMGN) has had its target price lifted by equities researchers at Mizuho from $303.00 to $352.00 in a recent research report, according to MarketBeat.

This change suggests a potential downside of 16.07% from the stock's current price. The firm currently has a 'neutral' rating on Amgen's medical research company stock.

Mizuho is not the only analyst to revise its target price for Amgen recently, as several other firms have done so in recent weeks and months.

More on Stocks

Stocks just now

Amazon Sees $500 Price Target as AI Supercycle Takes Hold

Stocks just now

Morgan Stanley Sees Path to $500 per Share as AWS Targets $1 Trillion Revenue

Stocks just now

Pershing Square Makes Amazon Its Fourth-Largest Holding by Dumping Alphabet

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy